| 证券代码：600170 | 证券简称：上海建工 | | | 公告编号：2025-054 | | --- | --- | --- | --- | --- | | 债券代码：240782 | 债券简称：24 | 沪建 | Y1 | | | 债券代码：240783 | 债券简称：24 | 沪建 | Y2 | | | 债券代码：241305 | 债券简称：24 | 沪建 | Y3 | | | 债券代码：241857 | 债券简称：24 | 沪建 | Y4 | | | 债券代码：243624 | 债券简称：25 | 沪建 | Y1 | | 上海建工集团股份有限公司 关于提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、担保情况概述 （一）2025 年 8 月，因申请各类贷款、银行承兑汇票、预付款保函、履约保 函和农民工工资保函等，上海建工集团股份有限公司（以下简称"公司"）为资产 负债率高于 70%的 18 家子公司提供 11.89 亿元担保，为资产负债率低于 70%的 1 家子公司提供 2.4 ...

●会议召开时间：2025年9月16日（星期二） 上午 11:00-12:00 ●会议网络平台：上海证券交易所上证路演中心（网址：http://roadshow.sseinfo.com/） ●会议召开方式：上证路演中心网络互动 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要提示： （一）投资者可在2025年9月16日上午11:00-12:00，通过互联网登录上证路演中心 （http://roadshow.sseinfo.com/），在线参与本次业绩说明会，公司将及时回答投资者的提问。 （二）投资者可于2025年9月9日(星期二)至9月15日(星期一)16:00前登录上证路演中心网站首页，点 击"提问预征集"栏目（http://roadshow.sseinfo.com/preCallQa），根据活动时间，选中本次活动或通过公 司邮箱ir@scg.com.cn向公司提问，公司将在说明会上对投资者普遍关注的问题进行回答。 五、联系方式及咨询办法 （一） 会议召开时间：2025年9 ...

Core Viewpoint - Shanghai Construction Group announced plans to hold a semi-annual performance briefing on September 16, 2025, from 11:00 to 12:00 [2] Company Summary - The company is preparing for a performance explanation meeting to discuss its financial results for the first half of 2025 [2] - The meeting is scheduled to take place in the morning, indicating a structured approach to investor relations and transparency [2] Industry Context - The announcement reflects the company's commitment to maintaining communication with stakeholders and providing insights into its operational performance [2] - Such events are common in the construction industry, where companies often seek to update investors on project developments and financial health [2]

| 证券代码：600170 | 证券简称：上海建工 | | | 公告编号：2025-053 | | --- | --- | --- | --- | --- | | 债券代码：240782 | 债券简称：24 | 沪建 | Y1 | | | 债券代码：240783 | 债券简称：24 | 沪建 | Y2 | | | 债券代码：241305 | 债券简称：24 | 沪建 | Y3 | | | 债券代码：241857 | 债券简称：24 | 沪建 | Y4 | | | 债券代码：243624 | 债券简称：25 | 沪建 | Y1 | | 上海建工集团股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要提示： 会议召开时间：2025 年 9 月 16 日（星期二） 上午 11:00-12:00 会议网络平台：上海证券交易所上证路演中心（网址： 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 9 月 9 日（星期二）至 9 月 15 日（星期一）16:00 前登 ...

Group 1 - Shanghai Municipal Engineering Group Co., Ltd. was fined 200,000 yuan by the Longgang District Water Affairs Bureau of Shenzhen for failing to implement soil and water conservation measures as per the approved plan [1] - The company was responsible for the construction of the Shenzhen Industrial Software Park slope greening and comprehensive improvement project, which included various engineering measures such as slope engineering and landscape greening [2] - The soil and water conservation plan for the project was approved on September 11, 2024, and included specific measures for both excavation and backfilling of the slope area [2][3] Group 2 - During a site inspection on May 23, 2025, it was found that the company did not implement the required soil and water conservation measures, leading to non-compliance with the approved plan [2][3] - The company had set up some temporary protective measures, but many of the required features, such as sedimentation tanks and soil bags, were either missing or not in use [2][3] - The violation was based on Article 18, Clause 2 of the Shenzhen Special Economic Zone Soil and Water Conservation Regulations, which mandates adherence to approved soil and water conservation plans [3]

Core Viewpoint - Shanghai Construction Group has received approval from the China Interbank Market Dealers Association to issue debt financing instruments, which will be used primarily for repaying maturing debts and other legal purposes [1][2]. Group 1 - The company has been granted a registration quota that is valid for two years from the date of the acceptance notice [1]. - The company can issue various types of debt financing instruments, including super short-term financing bonds, short-term financing bonds, medium-term notes, perpetual notes, asset-backed notes, and green debt financing instruments during the registration period [2]. - The underwriting for the issuance will be led by a consortium of financial institutions, including Dongfang Securities, China Construction Bank, China International Capital Corporation, CITIC Bank, and CITIC Securities [1]. Group 2 - The company will disclose the results of each issuance through channels recognized by the Dealers Association after the completion of the issuance [2]. - The company will provide timely updates on the progress of the debt financing tools based on the issuance situation [2].

Group 1 - The company has received approval from the China Interbank Market Dealers Association to issue debt financing instruments, with a registration validity of two years from the date of the notification [1] - The company plans to use the funds raised from the debt financing tools for repaying maturing debts and other legal and compliant purposes [2] - The underwriting will be jointly handled by several financial institutions, including Dongfang Securities, China Construction Bank, China International Capital Corporation, CITIC Bank, and CITIC Securities [1] Group 2 - The company can issue various types of debt instruments during the registration period, including super short-term financing bonds, short-term financing bonds, medium-term notes, perpetual notes, asset-backed notes, and green debt financing tools [1] - The company will disclose the progress of the issuance of debt financing tools in a timely manner based on the issuance situation [2]

Group 1 - Weisheng Information won four projects in August with a total amount of 85.5377 million yuan, accounting for 3.12% of the company's total revenue for 2024 [1] - Longqi Technology's shareholder plans to reduce its stake by up to 4.09%, equating to a maximum of 19.1916 million shares [1] - Guojin Modern's subsidiary received a drug registration certificate for injectable Nicardipine, used for treating unstable angina [3][4] Group 2 - SAIC Motor reported a total vehicle sales of 363,400 units in August, a year-on-year increase of 41.04%, with new energy vehicle sales reaching 129,800 units, up 49.89% [5] - Kuka Home plans to invest 1.124 billion yuan to build a self-owned base in Indonesia, aiming to enhance its international strategy [6] - Samsung Medical's subsidiary signed a contract for an intelligent meter project in Egypt worth 58.8 million USD, approximately 419 million yuan [8] Group 3 - North Vehicle Blue Valley's subsidiary reported a total production of 10,587 units in August, a year-on-year decrease of 15.13%, while sales increased by 3.47% [12] - Xianghe Industrial signed contracts worth 400 million yuan for railway fastener system components [13] - Hengrui Medicine's HRS9531 injection has received acceptance for its marketing authorization application [14] Group 4 - Hualu Hengsheng resumed normal production after completing maintenance on production facilities [16] - Shanghai Pharmaceuticals' hydrochloride verapamil injection passed the consistency evaluation for generic drugs [18] - Shanghai Construction received approval for debt financing tools with a registration period of two years [20] Group 5 - Kangli Elevator terminated the sale of its wholly-owned subsidiary due to the buyer's failure to obtain necessary approvals [21] - Times Wan Heng appointed Li Zhizhong as the new deputy general manager [22] - Hanma Technology reported a total truck sales of 1,051 units in August, a year-on-year increase of 58.05% [24] Group 6 - Wenzhou Hongfeng's subsidiary received a utility model patent certificate for a servo adjustment device [26] - Yibin Technology received a project designation from a domestic new energy vehicle company, with an estimated total sales of 243 million yuan over five years [28] - Star Ring Technology's H-share issuance application was accepted by the China Securities Regulatory Commission [30] Group 7 - Microchip Bio's vice president resigned for personal reasons [31] - Zhongxin Co. announced the resignation of a non-independent director due to personal reasons [32] - Changcheng Military Industry's vice chairman resigned due to retirement [35] Group 8 - Jiukang Bio received four invention patent certificates related to detection reagents [36] - Meino Bio's subsidiary changed its registered address [37] - Kuangda Technology announced a potential change in control due to a share transfer [38] Group 9 - China Rare Earth confirmed no undisclosed significant matters amid stock price fluctuations [72]

| 证券代码：600170 | 证券简称：上海建工 | | | 公告编号：2025-052 | | --- | --- | --- | --- | --- | | 债券代码：240782 | 债券简称：24 | 沪建 | Y1 | | | 债券代码：240783 | 债券简称：24 | 沪建 | Y2 | | | 债券代码：241305 | 债券简称：24 | 沪建 | Y3 | | | 债券代码：241857 | 债券简称：24 | 沪建 | Y4 | | | 债券代码：243624 | 债券简称：25 | 沪建 | Y1 | | 上海建工集团股份有限公司 关于债务融资工具获准注册的公告 二、公司在注册有效期内可分期公开发行超短期融资券、短期融资券、中期 票据、永续票据、资产支持票据、绿色债务融资工具等产品，也可定向发行相关 产品，每期发行时应确定当期主承销商、发行产品、发行规模、发行期限等要素。 发行完成后，应通过交易商协会认可的途径披露发行结果。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 经上海建工集团股份有限公司 ...

Core Viewpoint - The company reported a decline in revenue and net profit for the first half of 2025, but showed signs of improvement in the second quarter, leading to a maintained "buy" rating. Group 1: Financial Performance - In H1 2025, the company achieved revenue of 105.04 billion yuan, a year-on-year decrease of 28.04%, and a net profit attributable to shareholders of 710 million yuan, down 14.07% year-on-year [1] - The Q2 2025 revenue was 64.73 billion yuan, representing a year-on-year decline of 9.14% but a quarter-on-quarter increase of 60.55%. The net profit for Q2 was 889 million yuan, up 65.94% year-on-year and 595.82% quarter-on-quarter [1] - The comprehensive gross margin for H1 2025 was 8.28%, an increase of 0.66 percentage points year-on-year, while Q2 gross margin was 8.74%, a decrease of 0.41 percentage points year-on-year but an increase of 1.20 percentage points quarter-on-quarter [2] Group 2: Cost and Cash Flow - The expense ratio for H1 2025 was 7.69%, an increase of 1.36 percentage points year-on-year, with sales, management, R&D, and financial expense ratios at 0.23%, 3.57%, 2.94%, and 0.94%, respectively [3] - The company recorded a net reversal of impairment of 315 million yuan in H1 2025, compared to an impairment loss of 235 million yuan in the same period last year [3] - The net operating cash flow for H1 2025 was -18.48 billion yuan, a reduction in outflow by 4.14 billion yuan year-on-year, with a cash collection/payment ratio of 126%/143%, up 7.6 and 10.8 percentage points year-on-year [3] Group 3: Contract and Market Activity - The new contract amount for H1 2025 was 130.2 billion yuan, a year-on-year decrease of 37%, with Q2 new contracts at 65.7 billion yuan, down 28% year-on-year but showing a narrowing decline [4] - The company actively expanded into emerging businesses, securing 30.2 billion yuan in new contracts from six emerging sectors, accounting for 23% of total new contracts [4] - In the Yangtze River Delta region, the company secured 84% of new contracts, with Shanghai alone accounting for 90.5 billion yuan, a year-on-year decline of 42% [4] Group 4: Profit Forecast and Valuation - The company maintains profit forecasts for 2025-2027 at 2.302 billion, 2.426 billion, and 2.543 billion yuan, respectively [5] - The average PE ratio for comparable companies in 2025 is projected at 14 times, leading to a target price adjustment to 3.63 yuan, up from 3.11 yuan, while maintaining a "buy" rating [5]